Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | BBOX1 | O75936 | 5/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GRK2 | P25098 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL8397794 | 0.89 | BBOX1 (0.39) | TSHRBBOX1SLC22A1 | |
| Sulfuric Acid SCHEMBL7543975 | 0.86 | BBOX1 (0.38) | BBOX1SLC22A1 | |
| Tributylmethylammonium SCHEMBL268725 | 0.85 | MEN1 (0.39) | MEN1KMT2AALDH1A1TSHRBBOX1 | |
| Sulfuric Acid SCHEMBL15361710 | 0.84 | BBOX1 (0.46) | MEN1KMT2AALDH1A1TSHRBBOX1 | |
| Sulfuric Acid SCHEMBL6405441 | 0.81 | LSS (0.48) | KMT2ASLC22A1 | |
| Sulfuric Acid SCHEMBL781963 | 0.81 | LSS (0.48) | KMT2ASLC22A1 | |
| Sulfuric Acid SCHEMBL6257863 | 0.81 | LSS (0.48) | KMT2ASLC22A1 | |
| Sulfuric Acid SCHEMBL2544115 | 0.81 | LSS (0.48) | KMT2ASLC22A1 | |
| Sulfuric Acid SCHEMBL6054968 | 0.81 | LSS (0.48) | KMT2ASLC22A1 | |
| Sulfuric Acid SCHEMBL6261099 | 0.81 | LSS (0.48) | KMT2ASLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1635992-A | Solventless synthesis of hydrophilic phenol ester derivatives | PROCTER & GAMBLE (US) | 2005-07-06 | — | — | CN | disclosed |
| US-20020058824-A1 | Solventless synthesis of hydrophilic phenol ester derivatives | PROCTER & GAMBLE COMPANY, THE | 2002-05-16 | — | — | US | disclosed |
| EP-0577746-B1 | IMPROVED PROCESS FOR PREPARING PHENYL CHLOROACETATE | DU PONT (US) | 1996-02-28 | — | — | EP | disclosed |
| EP-0577746-A1 | IMPROVED PROCESS FOR PREPARING PHENYL CHLOROACETATE. | DU PONT (US) | 1994-01-12 | — | — | EP | disclosed |
| WO-1992016491-A1 | IMPROVED PROCESS FOR PREPARING PHENYL CHLOROACETATE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-10-01 | — | — | WO | disclosed |
| US-5069828-A | PROCESS FOR PREPARING BENZENESULFONATE SALTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-12-03 | — | — | US | disclosed |
| US-4985180-A | Process for preparing phenyl esters of substituted acids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-15 | — | — | US | disclosed |
| EP-0402048-A1 | Improved process for preparing benzenesulfonate salts | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058824-A1 | Solventless synthesis of hydrophilic phenol ester derivatives | MPHOSPH6, HACL2, PHKB | MEN1 4088/4885KMT2A 1638/4885ALDH1A1 4568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.